Search

The International Observership Program is open and accepting applications.

… The International Observership Program is open and accepting applications. Onsite visits are limited to 30 days and start dates are every other Monday. Please contact an MSK physician directly to arrange a visit and instructions on how to apply. Overview International Physicians currently employed outside

… Job Title Administrative Assistant II

Dr. Michael Offin treats mesothelioma and lung cancers at MSK, including BRAF-mutated tumors, offering clinical trials and personalized, patient-focused care.

… Dr. Michael Offin treats mesothelioma and lung cancers at MSK, including BRAF-mutated tumors, offering clinical trials and personalized, patient-focused care. At Memorial Sloan Kettering Cancer Center, science, compassion, and hope come together to drive powerful advances in medical research and patient

… Technical and Advisory Services Provided Cell lines and tumor tissues : We maintain a large repository of commonly used murine and human cell lines and tumor tissues. Xenografts : We establish xenograft models from cell lines, organoids or tumor samples provided by the investigator or supplied through

… The Gabriela Chiosis Lab Postdoctoral fellow/scholar position  is available immediately in a multidisciplinary team studying maladaptive changes in proteome-wide protein-protein interaction networks in disease. These efforts will be conducted in collaboration with scientists and clinicians at Memorial

… Job Title Research Technician Email [email protected] Lab Phone 212-639-2784

NEW YORK, September 21, 2003 - New research from Memorial Sloan Kettering Cancer Center (MSKCC), Cornell University, and The University of Connecticut describes a novel way of producing therapeutic nerve cells that can cure mice with Parkinson's-like disease. The work, which will be published in the October issue of Nature Biotechnology (available online September 21), provides the first evidence that cloned cells can cure disease in an animal model.

… Monday, September 1, 2003 Summary NEW YORK, September 21, 2003 - New research from Memorial Sloan Kettering Cancer Center (MSKCC), Cornell University, and The University of Connecticut describes a novel way of producing therapeutic nerve cells that can cure mice with Parkinson’s-like disease. The work

Sessions feature three 30-minute presentations on nanoscience, one each with strong orientation in biology, chemistry, and physics/applied mathematics. Presentations will be focused on discussion of recent work, although speakers will be expected to place the work in a context understandable to a broad audience.

… Refreshments: 5:00 p.m. New York Science: 5:30 – 7:00 p.m. Contact Phone: 212-998-8400 https://as.nyu.edu/departments/chemistry/research/nanoscience-and-materials/new-york-nanoscience-discussion-group.html Julie Kaplan   Email: [email protected] Phone Number: 212-998-8478 Office Address:  24 Waverly

The Memorial Sloan Kettering Cancer Alliance is a transformative initiative to improve the quality of cancer care and the lives of cancer patients by bringing evidence-based, world-class standards to community healthcare providers.

… The Memorial Sloan Kettering Cancer Alliance is a transformative initiative designed to improve the quality of cancer care and the lives of people with cancer by bringing evidence-based, world-class standards of care to community healthcare providers. The MSK Cancer Alliance accelerates the integration

Acoustic neuroma — also called vestibular schwannoma — is a type of noncancerous tumor within the skull. It can cause problems with movement, balance, and hearing. Memorial Sloan Kettering experts can help diagnose and treat this condition.

… Acoustic neuroma, also called vestibular schwannoma, is a type of benign (noncancerous) tumor. It starts in the cells that wrap around the hearing and balance nerve that connects your ear to your brain. Most acoustic neuromas grow very slowly. As this happens, the tumor begins to press on nearby nerves